| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 115524 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "P&C" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 58038 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 56512 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | true |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 37499 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 19014 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Asset Management" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 875 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Bank" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 99 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 30598 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 43005 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "AXA XL" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 19277 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 19925 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "AXA IM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 875 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Transversal & Other" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 1844 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Gross Written Premiums & Other Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 2233 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 New Business Value (NBV) (a)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 2233 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | true |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 New Business Value (NBV) (a)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 1747 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 New Business Value (NBV) (a)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 486 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 New Business Value (NBV) (a)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 695 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 New Business Value (NBV) (a)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 578 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 New Business Value (NBV) (a)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 959 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 New Business Value (NBV) (a)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 2199 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 2199 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | true |
|---|
| parent | "" |
|---|
| matched_label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 1822 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "confirmed" |
|---|
| confirmed_rev | 23318 |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 377 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 431 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 740 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 1028 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 49357 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Present Value of Expected Premiums (PVEP) (b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 49357 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | true |
|---|
| parent | "" |
|---|
| matched_label | "Present Value of Expected Premiums (PVEP) (b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 37103 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Present Value of Expected Premiums (PVEP) (b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 12254 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Present Value of Expected Premiums (PVEP) (b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 22858 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Present Value of Expected Premiums (PVEP) (b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 12651 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Present Value of Expected Premiums (PVEP) (b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 13847 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Present Value of Expected Premiums (PVEP) (b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 4.5 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 NBV Margin (a)/(b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 4.5 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | true |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 NBV Margin (a)/(b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 4.7 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 NBV Margin (a)/(b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 4 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 NBV Margin (a)/(b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 3 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 NBV Margin (a)/(b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 4.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 NBV Margin (a)/(b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 6.9 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "IFRS17/9 NBV Margin (a)/(b)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Total Assets" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 635.5 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Total Assets" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Goodwill" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 17.8 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Goodwill" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Other intangible assets" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 4.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Other intangible assets" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Shareholders' Equity group share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 47.2 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Shareholders' Equity group share" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Non-controlling Interests" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 2.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Non-controlling Interests" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Financing debt" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 15.8 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Financing debt" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Insurance contract liabilities" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 470.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Liabilities arising from insurance contracts and investment contracts with discretionary participation features contracts" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Present Value of Future Cash Flows" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 432.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "Balance Sheet" |
| "Liabilities" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Present Value of Future Cash Flows" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Risk Adjustment" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 3.1 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "Balance Sheet" |
| "Liabilities" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Risk Adjustment" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Contractual Service Margin (closing, pre-tax)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 33253 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Total Group (pre-tax)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Contractual Service Margin (closing, post-tax)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 25864 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Total Group (post-tax)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Retained Earnings" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 41.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Retained Earnings" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Undated Subordinated Debt" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 4.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Undated Subordinated Debt" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Other Comprehensive Income" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | -6.8 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Other Comprehensive Income" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Book Value per Share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1 |
|---|
| value | 24 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | | "Shareholders' equity excludes the other comprehensive income as well as the undated and deeply subordinated debt." |
|
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Book Value per Share" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Underlying Earnings Before Tax" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 11044 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "UE by LOB and Net Income" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Underlying Earnings Before Tax" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Underlying Earnings Group Share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 8368 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "UE by LOB and Net Income" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Underlying Earnings Group Share" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Subordinated Debt Charges (post-tax)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | -174 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "UE by LOB and Net Income" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Deeply Subordinated and Undated Subordinated Debt Charges" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Underlying Earnings for EPS" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 8195 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "UE by LOB and Net Income" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Underlying Earnings for EPS calculation" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Underlying Earnings Group Share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2024 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 8078 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "UE by LOB and Net Income" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Underlying Earnings Group Share" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Net Income Group Share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 9797 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "UE by LOB and Net Income" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Net Income Group Share" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Combined Ratio" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 90.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Combined Ratio" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Shares Outstanding (period-end)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "count" |
|---|
| scale | 1000000 |
|---|
| value | 2055.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | | "Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24." |
|
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "As at End of Period" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Average Shares Outstanding" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "count" |
|---|
| scale | 1000000 |
|---|
| value | 2124 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "During the Period (A)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "EPS" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1 |
|---|
| value | 4.53 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "EPS (B/A)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Underlying EPS" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1 |
|---|
| value | 3.86 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Underlying EPS (C/A)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Net Income ROE" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 18.8 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Net Income ROE" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Average Adjusted Shareholders' Equity" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 51.3 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | | "Excluding reserves for Other Comprehensive Income as well as undated and deeply subordinated debt (recorded through shareholders' equity)." |
|
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Average Adjusted Shareholders' Equity" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Underlying ROE" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 16 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Underlying ROE" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Debt Gearing" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 22.3 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Debt Gearing (G) = (B) / (E)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Financing Debt (senior)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 3.2 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Financing Debt" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Dated Subordinated Debt" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 12.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Dated Subordinated Debt" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Eligible Own Funds" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 56.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "Information on Solvency II" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Eligible Own Fund (EOF)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Solvency Capital Requirement" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 25.2 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "Information on Solvency II" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Solvency Capital Requirement (SCR)" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Solvency II Ratio" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 224 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | | "Information on Solvency II" |
|
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Solvency II Ratio" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Holdings Underlying Earnings" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | -1180 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Underlying Earnings Group share" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Closing Cash Balance at AXA SA" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 5.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | | "Includes liquid invested assets." |
|
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Closing Cash Balance at AXA SA" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Net cash remittance from subsidiaries" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 7.5 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | | "Includes exceptional cash remittances from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.4 billion in 2024) and AXA Life Europe (Euro +0.2 billion in 2024)." |
|
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Net cash remittance from subsidiaries" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Dividends" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 4.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Dividends" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Share buy-backs" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 4.7 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | | "On top of annual share buy-back, includes Euro +3.5 billion share buy-back in 2025 to offset the earnings dilution resulting from the disposal of AXA IM and Euro +0.7 billion share buy-back in 2024 from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.5 billion) and AXA Life Europe (Euro +0.2 billion)." |
|
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Share buy-backs" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Insurance Revenues (P&C)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 57656 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Revenues" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Current Accident Year Loss Ratio" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 66.9 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Current Accident Year Loss Ratio" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Prior Year Reserve Development Ratio" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | -1.1 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Prior Year Reserve Development Ratio" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|
| label | "Expense Ratio (P&C)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "percent" |
|---|
| scale | 1 |
|---|
| value | 24.8 |
|---|
| source | "financial_supplement" |
|---|
| note | "" |
|---|
| section_path | |
|---|
| footnotes | |
|---|
| is_subtotal | false |
|---|
| parent | "" |
|---|
| matched_label | "Expense Ratio" |
|---|
| wiki_page | "AXA/2025/FY/Financial supplement" |
|---|
| wiki_revision | 23318 |
|---|
| human_status | "unreviewed" |
|---|
| override_reason | "" |
|---|
| alt_source | "" |
|---|
|